Literature DB >> 848488

Inheritance of low erythrocyte catechol-o-methyltransferase activity in man.

R M Weinshilboum, F A Raymond.   

Abstract

Catechol-O-methyltransferase activity was measured in blood obtained from 373 randomly selected subjects aged 16-18, 262 consecutive adult blood donors, and 201 first-degree relatives of subjects with RBC COMT activity of less than 8 U. The distribution of RBC COMT activity in a randoly selected populations was apparently bimodal with a nadir at approximately 8 U. Of a randomly selected population, 23% had low RBC COMT activity (less than 8 U), Because of previous reports of a significant sibling-sibling correlation of RBC COMT activity and because of the presence of a subgroup of subjects with low enzyme activity, RBC COMT activity was measured in blood from first-degree relatives of probands with low erythrocyte enzyme activity in 48 families. The results of segregation analyses of the data were compatible with autosomal recessive inheritence of an allele for low RBC COMT activity. RBC COMT in blood samples from siblings of probands inthese families also showed an apparent biomodal distribution.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 848488      PMCID: PMC1685255     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  12 in total

1.  Calcium inhibition of rat liver catechol-O-methyltransferase.

Authors:  R M Weinshilboum; F A Raymond
Journal:  Biochem Pharmacol       Date:  1976-03-01       Impact factor: 5.858

2.  Enzymatic O-methylation of epinephrine and other catechols.

Authors:  J AXELROD; R TOMCHICK
Journal:  J Biol Chem       Date:  1958-09       Impact factor: 5.157

3.  Correlation of erythrocyte catechol-O-methyltransferase activity between siblings.

Authors:  R M Weinshilboum; F A Raymond; L R Elveback; W H Weidman
Journal:  Nature       Date:  1974-12-06       Impact factor: 49.962

4.  Catechol-O-methyltransferase activity in erythrocytes in Down's syndrome.

Authors:  K H Gustavson; L Wetterberg; M Bäckström; S B Ross
Journal:  Clin Genet       Date:  1973       Impact factor: 4.438

5.  Genetic control of platelet and plasma monoamine oxidase activity.

Authors:  A Nies; D S Robinson; K R Lamborn; R P Lampert
Journal:  Arch Gen Psychiatry       Date:  1973-06

6.  Methyltransferase enzymes in red blood cells.

Authors:  J Axelrod; C K Cohn
Journal:  J Pharmacol Exp Ther       Date:  1971-03       Impact factor: 4.030

7.  Microassay of human erythrocyte catechol-O-methyltransferase: removal of inhibitory calcium ion with chelating resin.

Authors:  F A Raymond; R M Weinshilboum
Journal:  Clin Chim Acta       Date:  1975-01-20       Impact factor: 3.786

8.  Erythrocyte soluble catechol-O-methyl transferase activity in primary affective disorder. A clinical and genetic study.

Authors:  E S Gershon; W Z Jonas
Journal:  Arch Gen Psychiatry       Date:  1975-11

9.  Reduced catechol-O-methyltransferase activity in red blood cells of women with primary affective disorder.

Authors:  C K Cohn; D L Dunner; J Axelrod
Journal:  Science       Date:  1970-12-18       Impact factor: 47.728

10.  Reduced monoamine oxidase activity in platelets: a possible genetic marker for vulnerability to schizophrenia.

Authors:  R J Wyatt; D L Murphy; R Belmaker; S Cohen; C H Donnelly; W Pollin
Journal:  Science       Date:  1973-03-02       Impact factor: 47.728

View more
  58 in total

Review 1.  Development of analytical technology in pharmacogenetic research.

Authors:  Ann K Daly
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-09-25       Impact factor: 3.000

Review 2.  The role of catechol-O-methyltransferase in the inactivation of catecholestrogen.

Authors:  C R Creveling
Journal:  Cell Mol Neurobiol       Date:  2003-06       Impact factor: 5.046

3.  Inhibitors of catechol-O-methyltransferase sensitize mice to pain.

Authors:  O Kambur; R Talka; O B Ansah; V K Kontinen; A Pertovaara; E Kalso; P T Männistö
Journal:  Br J Pharmacol       Date:  2010-12       Impact factor: 8.739

4.  Catechol O-methyltransferase pharmacogenomics and selective serotonin reuptake inhibitor response.

Authors:  Y Ji; J Biernacka; K Snyder; M Drews; L L Pelleymounter; C Colby; L Wang; D A Mrazek; R M Weinshilboum
Journal:  Pharmacogenomics J       Date:  2010-09-28       Impact factor: 3.550

Review 5.  Schizophrenia: genetic tools for unraveling the nature of a complex disorder.

Authors:  P Propping; M M Nöthen
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

Review 6.  Neurobehavioral evidence for changes in dopamine system activity during adolescence.

Authors:  Dustin Wahlstrom; Tonya White; Monica Luciana
Journal:  Neurosci Biobehav Rev       Date:  2009-12-21       Impact factor: 8.989

7.  A twin study on three enzymes (DBH, COMT, MAO) of catecholamine metabolism. Correlations with MMPI.

Authors:  H Winter; M Herschel; P Propping; W Friedl; F Vogel
Journal:  Psychopharmacology (Berl)       Date:  1978-04-14       Impact factor: 4.530

8.  Segregation and linkage studies of plasma dopamine-beta-hydroxylase (DBH), erythrocyte catechol-O-methyltransferase (COMT), and platelet monoamine oxidase (MAO): possible linkage between the ABO locus and a gene controlling DBH activity.

Authors:  L R Goldin; E S Gershon; C R Lake; D L Murphy; M McGinniss; R S Sparkes
Journal:  Am J Hum Genet       Date:  1982-03       Impact factor: 11.025

9.  A Randomized Controlled Trial of Green Tea Extract Supplementation and Mammographic Density in Postmenopausal Women at Increased Risk of Breast Cancer.

Authors:  Hamed Samavat; Giske Ursin; Tim H Emory; Eunjung Lee; Renwei Wang; Carolyn J Torkelson; Allison M Dostal; Karen Swenson; Chap T Le; Chung S Yang; Mimi C Yu; Douglas Yee; Anna H Wu; Jian-Min Yuan; Mindy S Kurzer
Journal:  Cancer Prev Res (Phila)       Date:  2017-09-13

10.  The Association of the COMT V158M Polymorphism with Endometrial/Ovarian Cancer in HNPCC Families Adhering to the Amsterdam Criteria.

Authors:  Katie A Ashton; Cliff J Meldrum; Mary L McPhillips; Janina Suchy; Grzegorz Kurzawski; Jan Lubinski; Rodney J Scott
Journal:  Hered Cancer Clin Pract       Date:  2006-05-15       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.